Cargando…
Chromatin accessibility analysis identifies GSTM1 as a prognostic marker in human glioblastoma patients
BACKGROUND: Glioblastoma (GBM) is a malignant human brain tumor that has an extremely poor prognosis. Classic mutations such as IDH (isocitrate dehydrogenase) mutations, EGFR (epidermal growth factor receptor) alternations, and MGMT (O6-methylguanine-methyltransferase) promoter hypermethylation have...
Autores principales: | Huang, Yin-Cheng, Lai, Joseph Chieh-Yu, Peng, Pei-Hua, Wei, Kuo-Chen, Wu, Kou-Juey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565064/ https://www.ncbi.nlm.nih.gov/pubmed/34732244 http://dx.doi.org/10.1186/s13148-021-01181-8 |
Ejemplares similares
-
The role of hypoxia-induced long noncoding RNAs (lncRNAs) in tumorigenesis and metastasis
por: Peng, Pei-Hua, et al.
Publicado: (2021) -
Comprehensive analysis of the glutathione S-transferase Mu (GSTM) gene family in ovarian cancer identifies prognostic and expression significance
por: Zhang, Juan, et al.
Publicado: (2022) -
GSTM3, but not IZUMO1, is a cryotolerance marker of boar sperm
por: Llavanera, Marc, et al.
Publicado: (2019) -
OTME-2. Regulation of chromatin accessibility in the hypoxic tumor microenvironment of glioblastoma
por: Dzwigonska, Monika, et al.
Publicado: (2021) -
GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death
por: Juang, Jyh-Ming Jimmy, et al.
Publicado: (2020)